Kathy Miller, MD
Indiana University
13
11
11
N/A
0
22
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+11 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Milan Radovich, PhD
Indiana University
Shared therapeutic areas:
Worked with same sponsors:
Ted Shih, PharmD
Geron Corporation
Shared therapeutic areas:
Worked with same sponsors:
Tamara N. Shenkier, MD
British Columbia Cancer Agency
Shared therapeutic areas:
Worked with same sponsors:
Melody A. Cobleigh, MD
Rush University Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Edith A. Perez, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
min yan
Henan Cancer Hospital
Shared therapeutic areas:
Norman Wolmark, MD
NSABP Foundation Inc
Shared therapeutic areas:
Worked with same sponsors:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
XiaoFeng Shen, MD
Nanjing Medical University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer
An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
iMETX (Individualized Metabolic RX): a Pilot Study
Impact of LOFT Therapy™ on Breast Cancer Survivors
Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment
Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer
A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer
A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer
Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
All 13 trials loaded